Moderna, Inc. MRNA
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$229.69$245.37
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 12.03% | -30.19% | -31.14% | -41.49% | -57.47% |
| Total Other Revenue | 32.23% | 35.83% | -6.04% | -1.57% | 3.42% |
| Total Revenue | 13.13% | -27.62% | -29.97% | -39.93% | -56.07% |
| Cost of Revenue | -22.62% | -29.90% | -34.76% | -33.41% | -28.50% |
| Gross Profit | 55.83% | 33.11% | 40.58% | 25.80% | -71.57% |
| SG&A Expenses | -7.73% | -10.15% | -11.96% | -13.29% | -17.94% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -19.84% | -26.56% | -31.09% | -30.12% | -26.74% |
| Operating Income | 41.09% | 25.57% | 32.05% | 22.08% | -28.59% |
| Income Before Tax | 13.45% | -4.82% | 7.87% | 23.26% | -34.00% |
| Income Tax Expenses | 262.16% | 252.38% | 214.29% | 217.39% | 71.32% |
| Earnings from Continuing Operations | 10.49% | -8.54% | 4.86% | 20.75% | -40.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.49% | -8.54% | 4.86% | 20.75% | -40.11% |
| EBIT | 41.09% | 25.57% | 32.05% | 22.08% | -28.59% |
| EBITDA | 45.22% | 28.38% | 35.00% | 23.88% | -37.81% |
| EPS Basic | 12.35% | -6.22% | 6.60% | 21.76% | -38.95% |
| Normalized Basic EPS | 42.76% | 26.12% | 33.71% | 23.18% | -36.35% |
| EPS Diluted | 12.08% | -6.12% | 6.67% | 21.82% | -38.25% |
| Normalized Diluted EPS | 42.39% | 26.14% | 33.73% | 23.20% | -36.10% |
| Average Basic Shares Outstanding | 2.39% | 2.01% | 1.62% | 1.30% | 1.11% |
| Average Diluted Shares Outstanding | 4.26% | 1.09% | 0.71% | 0.39% | -0.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |